Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer
- PMID: 3044107
- DOI: 10.1097/00000441-198807000-00011
Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer
Abstract
Steroid receptor status, cellular kinetics, abnormal proto-oncogene presence, and lymph node metastases all have been shown to provide prognostic information in breast cancer. The factors guide the choice of therapy and predict the course of the disease. Both disease-free survival and overall survival are predicted by these variables. Steroid receptors are the most reliable predictor of hormonal responsiveness. Lymph node involvement is crucial in determining the extent of the disease and the need for adjuvant therapy. Cellular kinetics and abnormal proto-oncogene presence predict tumor aggressiveness. Together these prognostic factors provide considerable information to the clinician.
Similar articles
-
[The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].Ned Tijdschr Geneeskd. 1998 Aug 1;142(31):1772-8. Ned Tijdschr Geneeskd. 1998. PMID: 9856143 Dutch.
-
Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.Asian Pac J Cancer Prev. 2014;15(21):9233-9. doi: 10.7314/apjcp.2014.15.21.9233. Asian Pac J Cancer Prev. 2014. PMID: 25422206
-
Progesterone and estrogen receptors as prognostic variables in breast cancer.Cancer Res. 1983 Jun;43(6):2985-90. Cancer Res. 1983. PMID: 6850609
-
Prognostic factors. Stage and receptor status in breast cancer.Cancer. 1992 Sep 15;70(6 Suppl):1755-64. doi: 10.1002/1097-0142(19920915)70:4+<1755::aid-cncr2820701617>3.0.co;2-g. Cancer. 1992. PMID: 1516031 Review.
-
Prognostic indicators in node-negative early stage breast cancer.Am J Med. 1992 May;92(5):539-48. doi: 10.1016/0002-9343(92)90751-v. Am J Med. 1992. PMID: 1580300 Review.
Cited by
-
Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.World J Surg. 1994 Jan-Feb;18(1):39-44. doi: 10.1007/BF00348190. World J Surg. 1994. PMID: 8197775 Review.
-
AN OVERVIEW OF PROGNOSTIC MARKERS IN BREAST CANCER.Med J Armed Forces India. 1999 Apr;55(2):129-132. doi: 10.1016/S0377-1237(17)30268-X. Epub 2017 Jun 26. Med J Armed Forces India. 1999. PMID: 28775603 Free PMC article. Review.
-
Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.Br J Cancer. 1995 May;71(5):974-80. doi: 10.1038/bjc.1995.188. Br J Cancer. 1995. PMID: 7734323 Free PMC article.
-
Oestrogen receptor: a stable phenotype in breast cancer.Br J Cancer. 1996 Jan;73(1):5-12. doi: 10.1038/bjc.1996.2. Br J Cancer. 1996. PMID: 8554983 Free PMC article. Review.
-
Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.Breast Cancer Res Treat. 1992;22(2):119-27. doi: 10.1007/BF01833341. Breast Cancer Res Treat. 1992. PMID: 1391976
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical